We studied the effects of the calcium channel blocker nicardipine on regional tissue Ca 2+ , Na + , K + , and water shifts in the brains of seven Sprague-Dawley rats after permanent occlusions of the middle cerebral artery. We also assessed the entry of [ 14 C]nicardipine into the brains of five rats; the highest concentrations of [ l4 C]nicardipine were in the infarcted area. Nicardipine treatment significantly reduced Ca 2+ accumulation in the middle cerebral artery territory by 60% compared with six untreated rats 6 hours after arterial occlusion. Eight 125-/tg/kg boluses of nicardipine given every 30 minutes starting 5 minutes after arterial occlusion also significantly reduced the Na + and K + shifts in the middle cerebral artery territory by 40% and 50%, respectively, 6 hours after arterial occlusion. Nicardipine appears to reduce Ca 2+ accumulation more than it reduces Na + and water accumulation and K + loss. Our results suggest that a calcium channel blocker can protect brain tissues in a model of focal cerebral infarction by directly reducing Ca 2+ entry into ischemic cells.
C erebral ischemia causes a rapid shift of Ca 2+ from the extracellular spaces into cells, manifested by a fall in extracellular calcium ionic activity and an increase in total tissue Ca 2+ concentration. 1 Excessive entry of Ca 2+ into cells has been called a "final common pathway of cell death". 2 In addition to disrupting basic cellular functions for which Ca 2+ acts as a messenger, an increase in intracellular Ca 2+ concentration activates membrane phospholipases, which break down membrane phospholipids and release free fatty acids, particularly arachidonic acid. 3 Metabolism of arachidonic acid produces prostaglandins and leukotrienes, 4 -6 which can further damage cell membranes. Reduction of Ca 2+ entry has been proposed as a therapeutic approach for cerebral ischemia. 78 Nicardipine is a dihydropyridine calcium channel blocker that has been shown to prevent or reverse vasospasm in animals. 910 This drug was recently tested in a clinical trial to assess its ability to prevent vasospasm in patients with subarachnoid hemorrhage and to reduce ischemic damage resulting from a reduction in cerebral blood flow. The results of that study show that nicardipine reduces the symptoms of vasospasm and improves neurologic outcome of the patients more than would be anticipated from the angiographic evidence of decreased vasospasm. 11 Allen et al 12 have reported similar results in patients treated with nimodipine. Their findings suggest that nicardipine and other calcium channel blockers may directly protect ischemic cells as well as improve blood flow to the brain. The effects of calcium channel blockers on ischemia have been attributed to reduced Ca 2+ entry into ischemic cells. 8 We recently described changes in tissue ion concentrations and water content in rat brains after middle cerebral artery occlusion (MCAo) . 11314 This model of regional cerebral ischemia 15 produces infarcts centered in the frontopyriform cortex. Ischemic areas show a more than twofold increase in Ca 2+ concentration, a threefold increase in Na + concentration, a >50% loss of K + , and a marked increase in tissue water content at the infarct site. 
Materials and Methods

Surgical Procedure
Twenty-one male Sprague-Dawley rats weighing 280-300 g were anesthetized with 30 mg/kg i.m. ketamine HC1 and 6 mg/kg i.m. xylazine. The right femoral vein and artery were cannulated with smalldiameter polyethylene catheters. The rats were ventilated through a tracheostomy with room air on a small rodent respirator. (Harvard Instruments, South Natick, Massachusetts). Arterial blood gases were monitored during the experiments. Blood pressure was continuously measured with a pressure transducer (Grass Instruments, Quincy, Massachusetts). The left middle cerebral artery (MCA) was occluded as described by Tamura et al. 15 Briefly, the MCA was exposed via a subtemporal craniectomy (2x3 mm) made with a microdrill between the foramen ovale and the optic foramen. The dura was opened with a hooked 25-gauge needle. The proximal MCA trunk was coagulated and divided distal to the lateral striate branch where the MCA crosses the olfactory stria. Six hours after MCAo the rats were anesthetized with 40 mg/kg pentobarbital and decapitated. The brains were removed and frozen and were analyzed by atomic absorption spectroscopy for ion concentrations and radioactive determination of [ 14 C]nicardipine distribution.
Experimental Groups
We divided the 21 rats into four groups. Group I. Seven rats were treated immediately after MCAo with 1 mg/kg nicardipine HC1 (Syntex Laboratories, Palo Alto, California) administered intravenously over 4 hours as 125-/ug/kg boluses in 200 fi\ saline every 30 minutes beginning 5 minutes after MCAo. The rats were decapitated 6 hours after MCAo, and the brains were analyzed for regional tissue Ca 2+ , Na + , and K + concentrations and for water content.
Group 2. Six untreated control rats received 200 fi\ saline every 30 minutes for 4 hours beginning 5 minutes after MCAo. The rats were decapitated and the brains were analyzed as in Group 1.
Group 3. Five rats were treated immediately after MCAo with [ l4 C]nicardipine HC1 (Syntex Laboratories) (specific activity 17.13 mCi/mM). Labeled drug was given in the same fashion as the unlabeled drug in Group 1. Group 3 rats were decapitated 6 hours after MCAo, and the brains were analyzed for regional distribution of [ l4 C]nicardipine. Group 4. Three intact rats were given intravenous nicardipine in the same manner as Group 1; no MCAo was carried out in Group 4. The rats were decapitated and the brains were analyzed as in Group 1.
Analysis of Ion Concentrations and Water Content
Immediately after decapitation, the brains were removed and cooled at -85° C until firm for cutting. A 4-mm-thick coronal slice was cut with a double razor blade assembly 4 mm posterior to the frontal poles. From this slice, four samples from each hemisphere were obtained with a sharpened metal tube (i.d. 3 mm) from the frontopyriform cortex (Area 1), the frontoparietal cortex (Area 2), the parasagittal cortex (Area 3), and the basal ganglia (Area 4); the sampling method has been described in detail. 11314 Infarcts were apparent in Area 1 of all rats by 6 hours after MCAo and were clearly visible on the cortical surface when 2 ml Evans blue was injected intravenously. Areas 3 and 4 were adjacent to the infarct.
The wet weight of each sample was obtained (Mettler Chemical Balance AE 163, Hightstown, New Jersey), and the samples were dried at 105° C for 24 hours. The samples were then transferred to a desiccating jar under vacuum for 20 minutes and weighed again to determine the dry weight. The samples were prepared for atomic absorption spectroscopic determinations of Ca 2+ , Na + , and K + concentrations 11314 by digestion in 1 ml concentrated nitric acid, heating to 45° C, and then drying at 95° C. The residue was dissolved again in 1 ml concentrated nitric acid. For Na + and K + measurements, a 0.1-ml aliquot was taken from the residual solution and diluted with 10 ml deionized water; the Na + and K + concentrations of the diluted solution were measured by atomic absorption spectroscopy (Perkin-Elmer 2280, Norwalk, Connecticut). For Ca 2+ measurements, the residual solutions were again dried at 95° C and heated at 550° C for 24 hours in a muffle oven (Thermolyne 1400, Thermolyne Corp., Dubuque, Iowa); after cooling, 2 ml of 2.5% lanthanum oxide in 0.1N HC1 was added.
All atomic absorption spectroscopy measurements were bracketed with two standards, one containing only the diluent and the other containing known amounts of Ca 2+ , Na + , or K + . Flame conditions, detection wavelengths, and sampling rates were optimized for maximal sensitivity and linearity. 
Analysis of [ l4 C]Nicardipine Distribution
Immediately after decapitation, the brains of the Group 3 rats were cooled for 10-20 minutes at -85° C. A 4-mm-thick coronal slice was cut 4 mm behind the frontal poles and divided into its two hemispheres. The remainder of the cerebral hemispheres posterior to the slice was divided into two hemispheres. We also sampled the liver. The four brain and one liver samples were weighed on a chemical balance and digested in 1.5 ml of 1 M NaOH for 12 hours at room temperature. The solutions were then placed in scintillation vials containing a mixture of Aquasol, Protosolethanol, and acetic acid in a ratio of 4:1:1.
Radioactivity was counted on a Beckman LS 7500 liquid scintillation counter (Fullerton, California) for 10 minutes. Quench correction was performed by the method of external standard: channel ratio. Blood samples were drawn 1 and 6 hours after MCAo. Serum was obtained by centrifugation, a 200 -fil aliquot was placed in a vial, and scintillation fluid was added as above; 30 mg [ 
Statistical Analyses
Differences in ion concentrations and water content between Groups 1 and 2 were analyzed by two-tailed t tests; p<0.05 indicated significance. Variance of mean ion concentrations and water content is given as standard deviation (SD); variance of mean changes in ion concentrations and water content is given as standard error of the mean (SEM). We used linear regression analysis to estimate the slope and correlation coefficient (r) of A [Ca] 
Results
Physiologic Parameters
Mean±SD Pao 2 was 90 ±6 mm Hg, Paco 2 37 ±5 mm Hg, and blood pH 7.40±0.70. In Group 2 rats, systolic blood pressures remained stable in the range 95-110 mm Hg. In Group 1 rats, pretreatment (baseline) systolic blood pressure ranged from 100 to 110 mm Hg. The first 125-/ng/kg bolus of nicardipine rapidly (within 20 seconds) reduced blood pressure by 60%. Systolic blood pressure remained low for 4 minutes before returning to 85-90% of baseline. A second bolus of nicardipine 30 minutes later similarly reduced blood pressure for 2 minutes before it returned to 90% of baseline. The next two injections of nicardipine lowered blood pressure transiently, but to a lesser extent. Thereafter, nicardipine injections caused minimal blood pressure changes, and blood pressure remained at 90% of baseline.
Ion Concentrations and Water Content
Mean ion concentrations and water content in the contralateral hemispheres of Groups 1 and 2 and values reported in normal, nonischemic rat brains 11314 are listed in 
Discussion
Our results indicate that nicardipine, administered intravenously in 125-/ng/kg boluses at 30-minute intervals after MCAo in rats, reduced ion shifts at the infarct site. Nicardipine-treated rats had significantly less tissue Ca 2+ and Na + accumulation, as well as less K + loss, than untreated control rats 6 hours after MCAo. The treatment effects were most prominent in Area 1, the histologic center of the infarct. Since tissue Ca 2+ , Na + , K + , and water shifts reflect cellular injury, 1315 our results suggest that nicardipine protected the infarct site.
At the outset of our experiments, we expected nicardipine to have little or no effect on Ca 2+ accumulation at the infarct site. If the drug had any beneficial effects, they should be most prominent in tissues surrounding the infarct, where nicardipineinduced vasodilation may improve collateral blood flow. 910 Our data suggested otherwise. Although there was a trend toward less ion and water shifts in Areas 2, 3, and 4, the reductions in these areas were not consistent and were smaller than those in Area 1. It is important to confirm these findings with histologic assessments of infarct volume.
Decreased ion shifts may result paradoxically from a decrease in blood flow. Ion entry into and clearance from tissues depend on blood flow. If blood flow is reduced, ion shifts should be correspondingly less. For example, less blood flow will reported no effect on blood flow in the central core of ischemia, whereas blood flow in the periphery of ischemia increased. 27 Unfortunately, these studies used reperfusion models, which are not comparable with permanent occlusion models. A recent doubleblind study of nimodipine by Germano et al 28 found a significant improvement in neurologic outcome and a reduction in infarct size 24 hours after MCAo in rats treated 1, 4, or 6 hours after occlusion. Although the best results were obtained in rats treated 1 hour after MCAo, Germano et al concluded that nimodipine had beneficial effects when administered up to 6 hours after the ischemic insult.
Three considerations complicate the interpretation of calcium channel blocker treatments in ischemia models. First, calcium channel blockers may improve blood flow without protecting the tissue against ischemia. For example, Harris et al 29 found that although nimodipine slightly improved cerebral blood flow at the infarct site in primates with MCAo, the drug increased edema formation and electrolyte derangement. Failure of calcium channel blockers to protect the cells is often attributed to their failure to improve cerebral blood flow. Second, calcium channel blockers may protect tissues without improving blood flow. Third, in most previous studies, entry of a drug into the brain was not measured. Since most calcium channel blockers may not penetrate the blood-brain barrier well, the lack of a therapeutic effect may be due to insufficient drug entry.
We measured the concentrations of nicardipine in the brains of treated rats with and without MCAo. Our data indicates that nicardipine uptake was greater in the ischemic territory than in the surrounding or normal cortical tissues. Grotta et al 30 have reported similarly greater uptake in ischemic cortical regions. The infarct site in Area 1 is also the region of greatest blood-brain barrier disruption after MCAo, as demonstrated by uptake of Evans blue. 13 -31 A nicardipine concentration of 2.3 x 10~8 M is about twice that required to cause vasodilation. 32 Most nicardipine was probably bound to cell membranes. 33 For example, at 0.27 nM (100 times lower than the concentrations of nicardipine we found in Area 1), 50% of the nimodipine is membrane-bound. Blood flow in the ischemic regions does not cease completely after MCAo. The finding that the greatest uptake of [ 14 C]nicardipine occurred at the infarct site suggests that there was sufficient blood flow to bring the drug there.
Total tissue Ca 2+ accumulation reflects Ca 2+ entry into cells. Our experiments suggest that nicardipine reduces Ca 2+ entry into ischemic cells. Nicardipine may reduce Ca 2+ accumulation in ischemic tissue by directly limiting Ca 2+ entry into ischemic cells. This is the most adequate explanation of our findings that nicardipine treatment reduced ion shifts most prominently at the infarct site and selectively reduced Ca 2+ accumulation more than Na + or water shifts. This pattern of ion shifts cannot be readily explained by improved collateral blood flow in the peri-infarct zone or by decreased blood flow at the infarct center due to hypotension. 34 The spatial distribution of [ l4 C]nicardipine suggests that the effects on ion shifts were greatest at the highest nicardipine concentrations.
It is possible that the greater effect of nicardipine on Ca 2+ accumulation at the infarct site is a generic consequence of any therapy that reduces cellular mortality in stroke. Ca 2+ accumulation may be a more sensitive reflection of tissue damage than Na + , K + , or water changes. This remains to be seen, however, since our particular approach has not been used to assess any other treatment in the rat MCAo model. In any case, these effects of nicardipine on ion shifts in this model were unexpected and they support the possibility that calcium channel blockers may act not only by improving blood flow but by directly reducing Ca 2+ entry into ischemic cells. Our experimental approach may be useful for screening therapies of focal ischemia. Our method is straightforward and should be easily reproducible in any laboratory possessing an atomic absorption spectrophotometer.
